Cognitive and behavioral effects of lamotrigine and topiramate in healthy volunteers

Neurology

Volumn 64, Issue 12, 2005, Pages 2108-2114

  Meador, Kimford J ^a,f   Loring, D W ^a   Vahle, V J ^b   Ray, P G ^c   Werz, M A ^d   Fessler, A J ^b   Ogrocki, P ^d   Schoenberg, M R ^d   Miller, J M ^e   Kustra, R P ^e  

^a GEORGETOWN UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c MEDICAL COLLEGE OF GEORGIA   (United States)

^d CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e GLAXOSMITHKLINE   (United States)

^f UNIVERSITY OF FLORIDA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LAMOTRIGINE; TOPIRAMATE;

ADULT; AMNESIA; ARTICLE; BEHAVIOR; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DEPRESSION; DIGESTIVE SYSTEM FUNCTION DISORDER; DIZZINESS; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FATIGUE; FEMALE; HEADACHE; HUMAN; HYPERTENSION; IRRITABILITY; MAJOR CLINICAL STUDY; MALE; NEUROPSYCHOLOGICAL TEST; NORMAL HUMAN; PARANOIA; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; RASH; RESPIRATORY TRACT DISEASE; SIDE EFFECT; SKIN TINGLING; SLEEP DISORDER;

ADULT; ANTICONVULSANTS; BRAIN; COGNITION DISORDERS; CROSS-OVER STUDIES; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; EPILEPSY; FEMALE; FRUCTOSE; HUMANS; MALE; MEMORY; MEMORY DISORDERS; MIDDLE AGED; MOOD DISORDERS; NEUROPSYCHOLOGICAL TESTS; PSYCHOMOTOR PERFORMANCE; REACTION TIME; REFERENCE VALUES; TREATMENT OUTCOME; TRIAZINES; VERBAL BEHAVIOR;

EID: 21144456722     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000165994.46777.BE     Document Type: Article

References (46)

1. Meador KJ. Cognitive effects of epilepsy and of antiepileptic medications. In: Wyllie E, ed. The treatment of epilepsy: principles and practice, 4th edition. Philadelphia: Lippincott Williams & Wilkins, 2004; 1215-1226.
2. Smith D, Baker G, Davies G, Dewey M, Chadwick DW. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993; 34:312-322.
3. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive and behavioral effects of carbamazepine and lamotrigine. Neurology 2001;8:1177-1182.
4. Cohen AF, Ashby L, Crowley D, Land G, Peck AW, Miller AA. Lamotrigine (BW430C) potential anticonvulsant. Effects on the central nervous system in comparison with phenytoin and diazepam. Br J Clin Pharmacol 1985;29:619-629.
5. Hamilton MJ, Cohen AF, Yuen AWC, et al. Carbamazepine and lamotrigine in healthy volunteers: relevance to early tolerance and clinical trial dosages. Epilepsia 1993;34:166-173.
6. Aldenkamp AP, Arends J, Bootsma HP, et al. Randomized double-blind parallel-group study comparing cognitive effects of a low-dose lamotrigine with valproate and placebo in healthy volunteers. Epilepsia 2002;43:19-26.
7. Gillham R, Baker G, Thompson, et al. Standardization of self-report questionnaire for use in evaluating cognitive, affective and behavioral side-effects of antiepileptic drug treatments. Epilepsy Res 1996; 24:47-55.
8. Brodie MJ, Overstall PW, Giorgi L, UK Lamotrigine Elderly Study Group. Multicentre, double-blind, randomized comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. Epilepsy Res 1999;37:81-87.
9. Steiner TJ, Dellaportas CI, Findley LJ, et al. Lamotrigine monotherapy in newly diagnosed untreated epilepsy: a double-blind comparison with phenytoin. Epilepsia 1999;40:601-607.
10. Burton LA, Harden C. Effect of topiramate on attention. Epilepsy Res 1997;27:29-32.
11. Martin R, Kuzniecky R, Ho S, et al. Cognitive effects of topiramate, gabapentin, and lamotrigine in healthy young adults. Neurology 1999; 52:321-327.
12. Glauser TA. Topiramate. Epilepsia 1999;40:S71-S80.
13. Jette NJ, Marson AG, Hutton JL. Topiramate add-on for drug-resistant partial epilepsy. Cochrane Database Syst Rev 2002;3:CD001417.
14. Thompson PJ, Baxendale SA, Duncan JS, Sander JWAS. Effects of topiramate on cognitive function. J Neurol Neurosurg Psychiatry 2000; 69:636-641.
15. Lee S, Sziklas V, Andermann F, et al. The effects of adjunctive topiramate on cognitive function in patients with epilepsy. Epilepsia 2003;44: 339-347.
16. Aldenkamp AP, Baker G, Mulder OG, et al. A multicenter, randomized clinical study to evaluate the effect on cognitive function of topiramate compared with valproate as add-on therapy to carbamazepine in patients with partial-onset seizures. Epilepsia 2000;41:1167-1178.
17. Meador KJ, Loring DW, Hulihan JF, Kamin M, Karim R. Differential cognitive and behavioral effects of topiramate and valproate. Neurology 2003;60:1483-1488.
18. Dunn LM, Dunn LM. Peabody Picture Vocabulary Test - third edition. Circle Pines, MN: American Guidance Services, 1997.
19. Meador KJ, Loring DW, Allen ME, et al. Comparative cognitive effects of carbamazepine and phenytoin in healthy adults. Neurology 1991;41: 1537-1540.
20. Meador KJ, Loring DW, Abney OL, et al. Effects of carbamazepine and phenytoin on EEG and memory in healthy adults. Epilepsia 1993;34: 153-157.
21. Meador KJ, Loring DW, Moore EE, et al. Comparative cognitive effects of phenobarbital, phenytoin and valproate in healthy subjects. Neurology 1995;45:1494-1499.
22. Meador KJ, Loring DW, Ray PG, et al. Differential cognitive effects of carbamazepine and gabapentin. Epilepsia 1999;40:1279-1285.
23. Ray PG, Meador KJ, Loring DW, Zamrini EY, Yang XH, Buccafusco JJ. Central anticholinergic hypersensitivity in aging. J Geriatr Psychiatr Neurol 1992;5:72-77.
24. Dodrill CB, Arnett JL, Sommerville KW, Sussman NM. Effects of differing dosages of vigabatrin (Sabril) on cognitive abilities and quality of life in epilepsy. Epilepsia 1995;36:164-173.
25. Buschke H, Fuld PA. Evaluating storage, retention, and retrieval in disordered memory and learning. Neurology 1974;24:1019-1025.
26. Spreen O, Strauss E. A compendium of neuropsychological tests: administration, norms and commentary. New York: Oxford University Press, 1998.
27. Kaplan E, Goodglass H, Weintraub S. The Boston Naming Test. Philadelphia: Lea & Febiger, 1983.
28. Henry JD, Crawford JR. A meta-analytic review of verbal fluency performance following cortical lesions. Neuropsychology 2004;18:284-295.
29. Lezak MD. Neuropsychological assessment. 3rd ed. New York: Oxford University Press, 1995.
30. Lachman R, Lachman JL, Butterfield EC. Cognitive psychology and information processing: an introduction. Hillsdale, NJ: Lawrence Erlbaum, 1979.
31. Golden CJ. Stroop Color and Word Test. A manual for clinical and experimental uses. Chicago: Stoelting, 1978.
32. Smith A. Symbol Digit Modalities Test. Manual. Los Angeles: Western Psychological Services, 1973.
33. Aldenkamp AP, Baker G, Pieters MS, Schoemaker HC, Cohen AF, Schwabe S. The Neurotoxicity Scale: the validity of a patient-based scale assessing neurotoxicity. Epilepsy Res 1995;20:229-239.
34. Abbetz L, Jacoby A, Baker GA, McNulty P. Patient based assessments of quality of life in newly diagnosed epilepsy patients: validation of the NEWQOL. Epilepsia 2000;41:1119-1128.
35. Lorr M, McNair DM, Droppleman LF. Manual: Profile of Mood States. San Diego, CA: Educational and Industrial Testing Service, 1971.
36. Devinsky O, Vickrey BG, Cramer J, et al. Development of the Quality of Life in Epilepsy (QOLIE) Inventory. Epilepsia 1995;36:1089-1104.
37. Ware JE, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-233.
38. Gilliam FG, Veloso F, Bomhof MA, et al. A dose-comparison trial of topiramate as monotherapy in recently diagnosed partial epilepsy. Neurology 2003;60:196-202.
39. Brodie MJ, Richens A, Yuen AWC. Double-blind comparison of lamotrigine and carbamazepine in newly diagnosed epilepsy. Lancet 1995; 345:476-479.
40. Privetera MD, Brodie MJ, Mattson RH, et al. Topiramate, carbamazepine and valproate monotherapy: double-blind comparison in newly diagnosed epilepsy. Acta Neurol Scand 2003;107:165-175.
41. Goodwin GM, Bowden CL, Calabrese JR, et al. A pooled analysis of 2 placebo-controlled 18-month trials of lamotrigine and lithium maintenance treatment in bipolar I disorder. J Clin Psychiatry 2004;65:432-441.
42. Calabrese JR, Bowden CL, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar disorder. J Clin Psychiatry 2003; 64:1013-1024.
43. Smith D, Baker G, Davies G, et al. Outcomes of add-on treatment with lamotrigine in partial epilepsy. Epilepsia 1993;34:312-322.
44. Gillham R, Baker G, Thompson R, et al. Standardization of a self-report questionnaire for use in evaluating cognitive, affective and behavioral side-effects of anti-epileptic drug treatments. Epilepsy Res 1996;24:47-55.
45. Chengappa KN, Gershon S, Levine J. The evolving role of topiramate among other mood stabilizers in management of bipolar disorder. Bipolar Disord 2001;3:215-232.
46. Johnson BA, Ait-Daoud N, Bowden CL, et al. Oral topiramate for treatment of alcohol dependence: a random controlled trial. Lancet 2003;361: 1677-1685.